Emerging advances of in vivo detection of chronic traumatic encephalopathy.

CONCLUSIONS: Limited data of in vivo CTE biomarkers with postmortem confirmation are available. While some data exist, they are limited by selection bias. It is unlikely that a single test will be sufficient to properly diagnosis and distinguish CTE from other neurodegenerative diseases such as Alzheimer disease or Frontotemporal Dementia. However, with a combination of fluid biomarkers, neuroimaging, and genetic testing, early detection may become possible.
PMID: 31287716 [PubMed - as supplied by publisher]

Source: The British Journal of Radiology - July 8, 2019 Category: Radiology Authors: Dallmeier JD, Meysami S, Merrill DA, Raji CA Tags: Br J Radiol Source Type: research